We are live on ! Find out more
IMPL

Impel Pharmaceuticals Inc. Common Stock

Delisted

IMPL was delisted on the 15th of December, 2023.

Name Holding Trade Value Shares
Change
Change in
Stake
KKRC
1
Kohlberg Kravis Roberts & Co
New York
$5.25M
NA
2
NVP Associates
California
$3.91M
5VM
3
5AM Venture Management
California
$3.66M
VC
4
Vivo Capital
California
$3.66M
VP
5
venBio Partners
California
$3.5M
Vanguard Group
6
Vanguard Group
Pennsylvania
$645K -$9.39K -6,194 -1%
LM
7
Lasry Marc
$519K
DA
8
DCF Advisers
Connecticut
$386K -$121K -79,543 -21%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$197K +$864 +570 +0.4%
LCM
10
Laurion Capital Management
New York
$158K
BCM
11
Bridgeway Capital Management
Texas
$80.4K
JGC
12
J. Goldman & Co
New York
$63K -$46.5K -30,650 -38%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$44.8K
State Street
14
State Street
Massachusetts
$32K
MP
15
McDonald Partners
Ohio
$25.7K +$12.9K +8,500 +73%
EP
16
EPIQ Partners
Minnesota
$23.7K
BlackRock
17
BlackRock
New York
$22.2K -$817 -539 -3%
RJA
18
Raymond James & Associates
Florida
$18.4K
CAPTRUST Financial Advisors
19
CAPTRUST Financial Advisors
North Carolina
$18.3K
BJL
20
Brighton Jones LLC
Washington
$18K
Northern Trust
21
Northern Trust
Illinois
$16.8K
TRCT
22
Tower Research Capital (TRC)
New York
$5.08K +$4.49K +2,962 +285%
LC
23
Lindbrook Capital
California
$3.88K
Morgan Stanley
24
Morgan Stanley
New York
$2.54K
DJSG
25
D.J. St. Germain
Massachusetts
$1.91K +$2.27K +1,500 New